Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Randomized, Cross- Over Study Examining Efficacy Of Pf-06372865 In A Photosensitivity Epilepsy Study Using Lorazepam As A Positive Control

NCT02564029 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02564029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02564029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Randomized, Cross- Over Study Examining Efficacy Of Pf-06372865 In A Photosensitivity Epilepsy Study Using Lorazepam As A Positive Control
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
December 16, 2015
Completion date
February 7, 2017
Enrollment
7 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

reflex epilepsy, photosensitive